Robotic Flight Simulator Surgery Market Analysis

Global Robotic Flight Simulator Surgery Market Overview

TheRobotic Flight Simulator Surgery Market Size was valued at USD 0.44 Billion in 2023. The Global Robotic Flight Simulator Surgery industry is projected to grow from USD 0.47 Billion in 2024 to USD 0.82 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.90% during the forecast period (2024 - 2032). The robotic flight simulator surgery refers to the introduction of virtual reality fundamentals to the robot-assisted surgery. The technology provides a multi-level curriculum, designed with various levels of difficulties in surgical procedures. 

Thus, robotic flight simulator teaches the surgeons and enable them with the required skills to perform robotic surgeries. Surgical robots have various advantages. They provide accuracy and perfection in the procedures with less loss of blood. This formulated the backgrounds for the development of the robotic flight simulator surgery market. Factors such as the growing demand for robotic surgery and rising healthcare expenditure are expected to be the major drivers for market growth during the forecast period.

In September 2022, Japan’s Ministry of Health, Labour and Welfare (MHLW) granted regulatory approval to Intuitive Surgical, Inc.’s latest surgical system – da Vinci SP for general surgeries as well as thoracic procedures not involving cardiac ones or intercostal approaches; urological procedures; gynecological cases; trans-oral head and neck surgeries. The company’s da Vinci SP surgical system will be rolled out soon by Intuitive Japan.

Medical Microinstruments S.p.A., an Italian-based company developing robotic microsurgery technology, raised $75 million in the month of July 2022. Deerfield Management led this round with other new investors, including RA Capital Management and Biostar Capital, while Andera Partners, Fountain Healthcare Partners, Panakès Partners and Sambatech were part of it too; the company also announced three new members joining its board of directors.

In June 2022, Intuitive Surgical started working together with Siemens Healthineers on the integration of scanning features during Ion Endoluminal procedures.

In March 2022, Quantum Surgical got FDA 510(k) clearance for Epionerobot, which is intended for cancer treatment.

CMR Surgical Ltd. signed a clinical study partnership contract with France’s leading cancer research center, Institut Curie, ranked among the best cancer treatment centers in the world for two years, effective September 2022.

Zimmer Biomet Holdings, Inc. was given FDA clearance for the Identity Shoulder System in September 2022 that would be used in shoulder replacement.

DePuy Synthes Orthopaedics Company (owned by Johnson & Johnson) recently received a nod from the Israeli Ministry of Health (AMAR)'s Medical Device Division approving VELYSTM Robotic-Assisted Solution commercialization across Israel starting February 2022.

In February 2021, CMR Surgical Ltd partnered with the Institute for Research into Cancer of the Digestive System (IRCAD) to offer laparoscopic and robotic surgical training. Minimally invasive surgery of any kind is a specialty area at IRCAD that will allow for the utilization of the Versius Surgical System in training.

AOT AG attained CE certification for its contact-free bone laser cutting robot, “CARLO,” in January 2021.

Robotic Flight Simulator Surgery Market Trends

According to the U.K. HealthCare approximately 970 robotic surgical procedures were performed within the region from 2012 to 2015. Moreover, the growing pharmaceutical and biotechnology sectors and the increasing prevalence of chronic diseases such as cancer, diabetes, and others boost the market growth. The U.S. is the largest market for biopharmaceuticals and accounts for one third of the global market. Moreover, it is estimated that the U.S. biopharmaceutical sector accounts for around 17% of all the domestic R&D funded by the U.S. businesses and added an estimated USD 1.2 trillion in the economic output of 2014. However, factors such as high price of surgical robots along with the risks associated with robotic surgeries are estimated to restrain the market growth during the forecast period. According to the Economic Cycle Research Institute in 2015, the average quoted prices of da Vinci robot models was estimated to range from USD 0.91 to USD 2.31 million.

Robotic Flight Simulator Surgery Market Segment Insights

The robotic flight simulator surgery market is segmented on the basis of application, method, and end-user. On the basis of application, the market is segmented into general surgery, cardiology surgery, neurosurgery, gynecology, and others. On the basis of method, the market is segmented into direct tele-manipulator and computer control. On the basis of end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Key Players in the Robotic Flight Simulator Surgery Market

The key players for the Robotic Flight Simulator Surgery Market are 

• Intuitive Surgical (U.S.)


• TransEnterix (U.S.)


• Titan Medical (Canada)


• Virtualincision (U.S.)


• AVRA (U.S.)


• Hansen Medical (U.S.)


• Corindus Vascular Robots (U.S.)


• Interventional Systems (U.S.)


• Stryker (U.S.)


• Mazor Robotics (Israel)

Robotic Flight Simulator Surgery Regional Insights

America dominates the robotic flight simulator surgery market owing to a well-developed healthcare sector and increasing adoption of new technologies. Additionally, the presence of well developed economies such as the U.S. and Canada and major players such as Intuitive Surgical, Stryker, Hansen Medical, and others boost the market growth. 

Europe is the second largest market for robotic flight simulator surgery. Factors such as the availability of funds for research, growing pharmaceutical and biotechnology sector, and rising per capita healthcare expenditure boost the market growth within the region. In 2014, according to the Office for National Statistics in the U.K. and the U.S., the per capita healthcare expenditure was about USD 4393 and USD 9985, respectively. On a regional basis, Europe is segmented into Western Europe and Eastern Europe. Western Europe is a major segment of the robotic flight simulator surgery market. On the other hand, Eastern Europe is estimated to be the fastest growing region.

Asia Pacific is estimated to be the fastest growing region for the market. This can be attributed to the increasing demand for robotic surgeries and huge patient population for chronic diseases such as cancer, diabetes, and others. According to a study published in the Cancer Biology & Medicine Journal in 2014, breast cancer was the most common type of cancers within the Asia Pacific region. In 2012, it was estimated that breast cancer accounted for 18% of the total reported cases within the region.

On the other hand, the Middle East and Africa holds the least share in the robotic flight simulator surgery market. This can be attributed to the presence of poor economies, stringent government policies, and lack of healthcare services especially within the African region. A majority of the market in the Middle East and Africa is held by the Middle East.

Intended Audience

• Pharmaceutical Companies


• Biotechnological Institutes


• Government and Private Laboratories


• Research and Development (R&D) Companies


• Medical Research Laboratories


• Market Research and Consulting Service Providers

Research Methodology

This report for Robotic Flight Simulator Surgery Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report also gives a broad study of the different market segments and regions.